Table 2.
Summary outcomes in CHW Intervention sites and control sites
| Facility | New ANC | % ANC in first trimester | % Four or more ANC | Facility birthsc | PNC | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pre-interventiona | Post interventionb | Pre-intervention | Post intervention | Pre-intervention | Post intervention | Pre-intervention | Post intervention | Pre-intervention | Post intervention | |
| Chifunga | 23.7 (5.4) | 39 (12.6) | 10.2 (7.9) | 37.5 (11.9) | 32.5 (21.2) | 50.3 (9.4) | 20 (4.8) | 23.4 (5.5) | 11.7 (7.6) | 15.7 (10.4) |
| Lisungwi | 55.7 (14.5) | 58.7 (13.3) | 14.4 (7.1) | 23.1 (9.1) | 26.5 (9.1) | 32.7 (6.6) | 65.3 (14.3) | 79 (13.2) | 32.3 (18.7) | 34.4 (24.7) |
| CHW intervention | 79.4 (14.9) | 97.7 (23.1) | 13.1 (5.0) | 28.6 (7.5) | 28.5 (3.9) | 39.0 (4.7) | 85.3 (14.0) | 102.4 (13.1) | 44 (21.3) | 50.1 (28.8) |
| Ligowe | 26.8 (11.2) | 34 (7.9) | 8.7 (6.1) | 24.3 (14.2)d | 29.2 (15.3) | 31.1 (11.8) | – | – | 0 (0) | 10 (11.8) |
| Luwani | 11.6 (3.8) | 14.3 (6.0) | 24.3 (15.4) | 25.1 (23.4) | 33.7 (15.1) | 40.5 (14.8) | 4.1 (3.4) | 2.9 (2.8) | 5.8 (2.9) | 4.7 (3.0) |
| Magaleta | 35.0 (8.6) | 31 (7.5) | 4.1 (4.2) | 9.2 (7.1) | 42.3 (10.4) | 55.1 (7.6) | 27.4 (6.4) | 26.4 (7.0) | 17.6 (6.0) | 17.5 (11.4) |
| Neno district hospital | 89.9 (23.2) | 85.5 (15.2) | 15.4 (5.7) | 19.2 (5.8) | 21.3 (7.6) | 21.5 (5.1) | 117 (18.6) | 125.4 (29.4) | 28.7 (15.6) | 45.4 (29.4) |
| Zalewa | 33.7 (6.2) | 37.7 (6.2) | 13.9 (5.2) | 19.4 (9.5) | 44.3 (9.9) | 46.1 (5.4) | – | – | 2.2 (1.7) | 7.5 (4.1) |
| Midzemba | – | – | – | – | – | – | – | – | – | – |
| Control sites | 197 (23.4) | 202.5 (17.2) | 12.5 (2.8) | 18.9 (5.0) | 30.6 (4.7) | 34.0 (3.0) | 148.5 (19.5) | 154.7 (27.4) | 54.3 (14.1) | 85.1 (39.1) |
Summary statistics of outcomes in intervention and synthetic units.
NB
Values are mean (SD) unless otherwise stated.
% Percentage.
aPre-intervention: March 2014 to February 2015(12 months).
bPost-intervention period March 2015 to June 2016(16 months).
cTwo facilities had no capacity to provide intrapartum care during the study period.
dAveraged over 15 months as data for one month was missing in the post-intervention period. Midzemba did not report any of the outcomes of interest during the study period.